Is it Alzheimer’s? How to pare down the possibilities
Current Psychiatry. 2008 January;07(01):53-66
January 1, 2008|Psychiatry
Author and Disclosure Information
A clinical guide to rule out other dementing diseases and rare reversible causes.
Related resources
- Morris JC. Dementia update 2005. Alzheimer Dis Assoc Disord 2005;19:100-17.
- Boeve BF. A review of the non-Alzheimer dementias. J Clin Psychiatry 2006;67(12)1985-2001.
- Medscape. Alzheimer’s disease resource center. www.medscape.com/resource/alzheimers.
- Donepezil • Aricept
- Memantine • Namenda
- Galantamine • Razadyne
- Rivastigmine • Exelon
Dr. Gebretsadik reports no financial relationship with any company whose products are mentioned in this article or with manufacturers of competing products.
Dr. Grossberg receives grant/research support from Abbott Laboratories, Bristol-Myers Squibb, Forest Laboratories, Eli Lilly and Company, Novartis, Pfizer Inc., Wyeth, Elan, Myriad, Ono Pharmaceutical, and the Alzheimer’s Disease Cooperative Study Consortium. He is a consultant to Bristol-Myers Squibb, Forest Laboratories, GlaxoSmithKline, Janssen Pharmaceutica, Novartis, AstraZeneca, Wyeth, Pfizer Inc., Takeda, and Sepracor.
